4383 Medical Drive
Suite 4077
San Antonio, TX
78229
(210) 593-2514
Select References
Gunn SR. The vanguard has arrived in the clinical laboratory: array-based karyotyping for prognostic markers in CLL. J Mol Diagn 2010, (in press). 
Yeh I-T, Martin M, Robetorye R, Boalla A, McCaskill C, Shah R, Gorre M, Mohammed M, Gunn S. Clinical validation of an array CGH test for HER2 status in breast cancer reveals that polysomy 17 is a rare event. Modern Pathology 2009, 22(9);1169-1175.
Gunn S, Hibbard M, Lowery-Nordberg M, Mellink C, Bahler D, Abruzzo L, Enriquez E, Gorre M, Mohammed M, Robetorye R. Atypical 11q deletions identified by array CGH may be missed by FISH panels for prognostic markers in chronic lymphocytic leukemia. Leukemia 2009, 23:1011-1017.
Gunn S, Mohammed M, Gorre M, Cotter P, Kim J, Bahler D, Preobrazhensky S, Higgins R, Bolla A, Ismail S, de Jon D, Eldering E, van Oers M, Mellinck C, Keating M, Schlette E, Abruzzo L and Robetorye R (2008) Whole-genome scanning by array CGH as a clinical tool for risk assessment in chronic lymphocytic leukemia. Journal of Molecular Diagnostics 2008, 10:442–45.
Higgins RA, Gunn SR and Robetorye RS. Clinical application of array-based comparative genomic hybridization for the identification of prognostically important genetic alterations in chronic lymphocytic leukemia (2008) Molecular Diagnosis and Therapy, 12 (5): 271-280.
Shelly Gunn, I-Tien Yeh, Irina Lytvak, Budi Tirtorahardjo, Natasha Dzidic, Soheila Zadeh, Jaeweon Kim, Chris McCaskill, Lony Lim, Mercedes Gorre, Mansoor Mohammed. Clinical array-based karyotyping of breast cancer with equivocal HER2 status resolves gene copy number and reveals chromosome 17 complexity. BMC Cancer 2010, 10:396 (28 July 2010) http://www.biomedcentral.com/1471-2407/10/396